Andrea Citterio

Andrea Citterio

Auto-generated profile, based on publicly available information

Andrea Citterio

Laboratory of Molecular Biology, Scientific Institute, IRCCS Eugenio Medea, Bosisio Parini, Lecco, Italy

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2010 in Journal of Biological Chemistry
Verified
Journal Article
Open access
NMNicola Manfrini
Nicola Manfrini
IGIlaria Guerini
Ilaria Guerini
ACAndrea Citterio
Andrea Citterio
GLGiovanna Lucchini
Giovanna Lucchini
MLMaria Pia Longhese
Maria Pia Longhese
Meiotic recombination requires the formation of programmed Spo11-dependent DNA double strand breaks (DSBs). In Saccharomyces cerevisiae, the Sae2 protein and the Mre11-Rad50-Xrs2 complex are necessary to remove the covalently attached Spo11 protein from the DNA ends, which are then resected by so far unknown nucleases. Here, we demonstrate that phosphorylation of Sae2 Ser-267 by cyclin-dependent kinase 1 (Cdk1) is required to initiate meiotic DSB resection by allowing Spo11 removal from DSB ends. This finding suggests that Cdk1 activity is required for the processing of Spo11-induced DSBs, thus providing a mechanism for coordinating DSB resection with progression through meiotic prophase. Furthermore, the helicase Sgs1 and the nucleases Exo1 and Dna2 participate in lengthening the 5'-3' resection tracts during meiosis by controlling a step subsequent to Spo11 removal.

13 December 2013 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
ACAndrea Citterio
Andrea Citterio
AAAlessia Arnoldi
Alessia Arnoldi
EPELENA PANZERI
ELENA PANZERI
MDMaria Grazia D’angelo
Maria Grazia D’angelo
Massimiliano FilostoMassimiliano Filosto
Massimiliano Filosto
MBMaria Teresa Bassi
Maria Teresa Bassi

26 September 2015 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
ACAndrea Citterio
Andrea Citterio
AAAlessia Arnoldi
Alessia Arnoldi
EPELENA PANZERI
ELENA PANZERI
LMLuciano Merlini
Luciano Merlini
MDMaria Grazia D’angelo
Maria Grazia D’angelo
MBMaria Teresa Bassi
Maria Teresa Bassi

14 April 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AMAndrea Martinuzzi
Andrea Martinuzzi
DMDomenico Montanaro
Domenico Montanaro
MVMarinela Vavla
Marinela Vavla
GPGabriella Paparella
Gabriella Paparella
PBPAOLO BONANNI
PAOLO BONANNI
MBMaria Teresa Bassi
Maria Teresa Bassi
Hereditary spastic paraplegias (HSP) are a composite and genetically heterogeneous group of conditions mainly expressed by the impairment of the central motor system (“pure” forms). The involvement of other components of the central nervous system or of other systems is described in the “complicate” forms. The definition of an investigation protocol capable, by assembling clinical and paraclinical indicators to fully represent the extent of the motor system impairment, would help both the clinical handling of these conditions and contribute to our understanding of their pathogenesis. We applied a clinical and paraclinical protocol which included tools exploring motor and non motor functioning, neurophysiology and MRI to a composite cohort of 70 molecularly defined HSP patients aged 3 to 65, to define for each indicator its significance in detailing the presence and the severity of the pathology. Clinically increased deep tendon reflexes and lower limb (LL) weakness are constant findings in all patients. The “complicated” forms are characterized by peripheral motor impairment, cognitive and cerebellar involvement. The Spastic Paraplegia Rating Scale efficiently reflects the severity of functional problems and correlates with disease duration. Neurophysiology consistently documents the impairment of the central motor pathway to the LLs. Nevertheless, the upper extremities and sensory system involvement is a frequent finding. MRI diffusion tensor imaging (DTI) highlighted a significant alteration of FA and MD. Combining the sampling of the various portion of the cortico-spinal tract (CST) DTI consistently discriminated patients from controls. We propose a graded clinical and paraclinical protocol for HSP phenotype definition, indicating for each tool the discriminative and descriptive capacity. Our protocol applied to 9 different forms of HSP showed that the functional impairment often extends beyond the CST. The novel DTI approach may add significant elements in disease recognition, staging and mapping.

4 July 2017 in European Radiology
Verified
Journal Article
Closed access
PDF file
RRRomina Romaniello
Romina Romaniello
FAFilippo Arrigoni
Filippo Arrigoni
EPELENA PANZERI
ELENA PANZERI
APAndrea Poretti
Andrea Poretti
AMAlessia Micalizzi
Alessia Micalizzi
RBRenato Borgatti
Renato Borgatti

3 July 2014 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
RLRocco Liguori
Rocco Liguori
MGMaria Pia Giannoccaro
Maria Pia Giannoccaro
AAAlessia Arnoldi
Alessia Arnoldi
ACAndrea Citterio
Andrea Citterio
CTCaterina Tonon
Caterina Tonon
MBMaria Teresa Bassi
Maria Teresa Bassi